×
Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Russia to Vaccinate Medics for Coronavirus in August

Russia has raced to develop a coronavirus vaccine in recent months. Maxim Shipenkov / EPA / TASS

Russia plans to administer its experimental coronavirus vaccine on healthcare professionals next month before its clinical trials are completed, Health Minister Mikhail Murashko said Thursday.

Russia’s adenoviral vector-based vaccine developed by military and government researchers is in Phase II trials with plans to launch the next and final phase sometime after Aug. 3. The vaccine “will be widely used in parallel with Phase III trials,” Interfax quoted Murashko as saying to reporters.

“We are now looking at what categories [will receive the vaccine first]. These are primarily medical workers and those who deal with sick people the most, so the risk categories will be offered a vaccine,” Murashko said.

He added that groups at higher risk of getting infected with Covid-19, like older people or those with health conditions, will also be prioritized for the vaccine. The minister did not estimate when that would happen.

Dozens of civilian and military volunteers undergoing Phase I trials of the vaccine were released Monday. The Health Ministry will decide whether the vaccine is effective based on the studies' results, Interfax reported.

Murashko said 800 people will take part in Phase III trials.

“In parallel, we’ll begin scaling and production, and the most at-risk groups will also be invited to vaccinate voluntarily,” Interfax quoted him as saying. 

“As a result of all this, we’ll have large-scale production and large-scale application.”

Russia’s military on Tuesday said the vaccine was “ready” following the Phase I trials. Health officials were more cautious, saying the trials are still ongoing and the state registration process is expected to begin after Aug. 3.

The head of Russia’s sovereign wealth fund that finances the trials has said he hopes to produce 200 million doses of the coronavirus vaccine with foreign partners by the end of 2020.

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more